Vestibular Mucosa Thickness Measured by Ultrasound in Patients Affected by Vestibulodynia: A Case-Control Study
- PMID: 33588370
- PMCID: PMC8072142
- DOI: 10.1016/j.esxm.2020.100320
Vestibular Mucosa Thickness Measured by Ultrasound in Patients Affected by Vestibulodynia: A Case-Control Study
Abstract
Introduction: A multifactorial etiology has been implicated in the development and maintenance of vestibulodynia (VBD), and atrophic changes of the vestibular mucosa have been observed in many patients.
Aim: To assess the vestibular mucosa thickness in patients with VBD by comparing this sample with a control group of healthy fertile women and postmenopausal patients with symptoms of genitourinary syndrome of menopause (GSM).
Methods: Vestibular mucosa thickness was measured with a 20 MHz ultrasound probe (DermaScan C, Cortex Technology, Denmark), including both the epidermis and dermis.
Main outcome measures: All women were evaluated by anamnesis, physical examination, and self-report symptoms. Thickness of the vestibular mucosa (expressed in micrometers) was determined by the B-mode, excluding the hyperechogenic entrance echo and hypoechogenic subcutis. Clinical data related to VBD and GSM were recorded using a 0- to 10-point visual analog scale related to dyspareunia and vulvar pain/burning (0 = no pain; 10 = worst possible pain).
Results: A total of 85 patients were recruited: 24 with VBD, 20 with GSM-related symptoms, and 20 matched controls. Vestibular mucosa thickness measurements were not significantly different between the VBD (mean ± DS: 1,092.5 ± 226.1 μm) and GSM groups (1,059.7 ± 221.5 μm), while the parameter was significantly lower (P < .01) than the control group (1,310.6 ± 250.0 μm). Correlation analysis in the VBD and GSM groups between low vestibular mucosa thickness and symptom intensity (burning/pain and dyspareunia) showed a significant correlation.
Conclusion: Patients with VBD have a vestibular mucosa with a lower thickness than healthy women of the same age, with an almost identical value to that found in postmenopausal women. Furthermore, a low vestibular mucosa thickness in the VBD and GSM groups showed a significant correlation with burning/pain intensity and dyspareunia severity. F Murina, S Barbieri, C Lubrano, MD, et al. Vestibular Mucosa Thickness Measured by Ultrasound in Patients Affected by Vestibulodynia: A Case-Control Study. Sex Med 2021;9:100320.
Keywords: Dyspareunia; High-Frequency Ultrasound; Vestibulodynia; Vulvar Mucosa; Vulvodynia.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Figures


Similar articles
-
Evaluation of polygenic risk scores for hormones and receptors levels in patients with vestibulodynia: a case-control study.J Sex Med. 2025 Apr 8;22(3):483-490. doi: 10.1093/jsxmed/qdae201. J Sex Med. 2025. PMID: 39799433
-
Dyspareunia Related to GSM: Association of Total Vaginal Thickness via Transabdominal Ultrasound.J Sex Med. 2019 Dec;16(12):2038-2042. doi: 10.1016/j.jsxm.2019.08.019. Epub 2019 Sep 18. J Sex Med. 2019. PMID: 31542351
-
Fractional CO2 Laser Treatment of the Vestibule for Patients with Vestibulodynia and Genitourinary Syndrome of Menopause: A Pilot Study.J Sex Med. 2016 Dec;13(12):1915-1917. doi: 10.1016/j.jsxm.2016.10.006. Epub 2016 Nov 15. J Sex Med. 2016. PMID: 27864031
-
Sexual Function in Women Suffering From Genitourinary Syndrome of Menopause Treated With Fractionated CO2 Laser.Sex Med Rev. 2017 Oct;5(4):486-494. doi: 10.1016/j.sxmr.2017.07.003. Epub 2017 Aug 23. Sex Med Rev. 2017. PMID: 28843942 Review.
-
Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women.Front Endocrinol (Lausanne). 2019 Aug 21;10:561. doi: 10.3389/fendo.2019.00561. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31496993 Free PMC article. Review.
Cited by
-
Reduced concentrations of vaginal metabolites involved in steroid hormone biosynthesis are associated with increased vulvar vestibular pain and vaginal muscle tenderness in provoked vestibulodynia: An exploratory metabolomics study.Mol Pain. 2021 Jan-Dec;17:17448069211041853. doi: 10.1177/17448069211041853. Mol Pain. 2021. PMID: 34505814 Free PMC article.
-
Clinical Evidence Regarding Spermidine-Hyaluronate Gel as a Novel Therapeutic Strategy in Vestibulodynia Management.Pharmaceutics. 2024 Nov 12;16(11):1448. doi: 10.3390/pharmaceutics16111448. Pharmaceutics. 2024. PMID: 39598571 Free PMC article.
-
Establishing Reference Values for Vaginal Vestibule Elastography in Healthy Postmenopausal Women.Cureus. 2024 Aug 31;16(8):e68294. doi: 10.7759/cureus.68294. eCollection 2024 Aug. Cureus. 2024. PMID: 39350872 Free PMC article.
-
Efficacy of Two Laser Treatment Strategies for Breast Cancer Survivors With Genitourinary Syndrome of Menopause.Cureus. 2023 May 5;15(5):e38604. doi: 10.7759/cureus.38604. eCollection 2023 May. Cureus. 2023. PMID: 37284382 Free PMC article.
References
-
- Bornstein J., Goldstein A.T., Stockdale C. ISSVD, ISSWSH, and IPPS consensus terminology and classification of persistent vulvar pain and vulvodynia. J Sex Med. 2016;13:607–612. - PubMed
-
- Harlow B.L., Stewart E.G. A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc. 2003;58:82. - PubMed
-
- Pukall C.F., Goldstein A.T., Bergeron S. Vulvodynia: Definition, prevalence, impact, and pathophysiological factors. J Sex Med. 2016;13:291–304. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical